Actively Recruiting
Real World European Investigation of Safety and Clinical Efficacy of the EVOQUE System (TRISCEND III EU)
Led by Edwards Lifesciences · Updated on 2024-10-31
500
Participants Needed
2
Research Sites
469 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a prospective, single-arm, multi-center, real-world study of an the Edwards EVOQUE system.
CONDITIONS
Official Title
Real World European Investigation of Safety and Clinical Efficacy of the EVOQUE System (TRISCEND III EU)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- The local heart team determines the patient is suitable for transcatheter tricuspid valve replacement with the EVOQUE system according to current instructions for use.
- Patient agrees to attend follow-up assessments.
- Patient has provided written informed consent for study participation.
You will not qualify if you...
- Patient is currently participating in another interventional biologic, drug, or device clinical study that has not met its primary endpoints.
- Patient is considered part of a vulnerable population.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Herz-und Diabeteszentrum NRW
Bad Oeynhausen, Germany
Actively Recruiting
2
Inselspital
Bern, Switzerland
Not Yet Recruiting
Research Team
T
TMTT Clinical
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here